AnalystsSwayampakula RamakanthSwayampakula Ramakanth's Stock Forecasts
AnalystsSwayampakula Ramakanth
Analyst Ranking
Top 8%
#359 out of 5017 analysts
Average Return
+4.81%
Win Rate
40%219 out of 551
Risk vs Reward
Poor
Good
Swayampakula Ramakanth's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Janux Therapeutics IncJANX | +645.28% | $7.09 | $52.84 | 2023-11-12 - 2024-11-12 | Buy |
Immunogen IncIMGN | +559.55% | $4.45 | $29.35 | 2023-03-01 - 2023-11-30 | Buy |
Celcuity IncCELC | +492.79% | $9.29 | $55.07 | 2025-03-31 - 2025-09-15 | Buy |
Immunogen IncIMGN | +491.73% | $4.96 | $29.35 | 2022-12-29 - 2023-11-30 | Buy |
Immunogen IncIMGN | +432.67% | $5.51 | $29.35 | 2023-04-30 - 2023-11-30 | Buy |
Swayampakula Ramakanth Analyst Color
Get additional color on Swayampakula Ramakanth's coverage of popular stocks
Swayampakula Ramakanth's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Dianthus Therapeutics IncDNTH | 7 | Buy | $40.00 | +7.99% | Reiterates | 8 days ago |
Personalis IncPSNL | 17 | Buy | $8.50 | +43.34% | Reiterates | 9 days ago |
Collplant Biotechnologies LtdCLGN | 10 | Buy | $11.00 | +318.25% | Reiterates | a month ago |
Precigen IncPGEN | 13 | Buy | $8.50 | +136.77% | Reiterates | a month ago |
Pyxis Oncology IncPYXS | 10 | Buy | $5.00 | +163.16% | Reiterates | a month ago |
Celcuity IncCELC | 9 | Buy | $66.00 | +19.85% | Maintains | a month ago |
Actuate Therapeutics IncACTU | 2 | Buy | $20.00 | +185.71% | Reiterates | a month ago |
Aethlon Medical IncAEMD | 2 | Hold | $1.50 | +105.20% | Reiterates | a month ago |
Vor Biopharma IncVOR | 13 | Buy | $3.00 | +87.50% | Reiterates | a month ago |
X4 Pharmaceuticals IncXFOR | 17 | Buy | $3.50 | +17.06% | Maintains | a month ago |
Humacyte IncHUMA | 2 | Buy | $3.00 | +96.08% | Maintains | a month ago |
Mirum Pharmaceuticals IncMIRM | 2 | Buy | $80.00 | +7.83% | Maintains | a month ago |
Delcath Systems IncDCTH | 14 | Buy | $31.00 | +190.53% | Maintains | a month ago |
Nuvalent IncNUVL | 4 | Buy | $130.00 | +63.79% | Maintains | 3 months ago |
Ocugen IncOCGN | 20 | Buy | $7.00 | +483.33% | Reiterates | 3 months ago |
Elevation Oncology IncELEV | 9 | Hold | $0.36 | -1.37% | Downgrades | 3 months ago |
Eton Pharmaceuticals IncETON | 8 | Buy | $35.00 | +96.85% | Maintains | 4 months ago |
Unicycive Therapeutics IncUNCY | 1 | Buy | $90.00 | +2,184.26% | Assumes | 4 months ago |
Mediwound LtdMDWD | 18 | Buy | $31.00 | +80.86% | Maintains | 4 months ago |
Renovorx IncRNXT | 3 | Buy | $3.00 | +136.22% | Reiterates | 4 months ago |
Alx Oncology Holdings IncALXO | 15 | Buy | $2.00 | +90.48% | Maintains | 4 months ago |
Corcept Therapeutics IncCORT | 20 | Buy | $145.00 | +108.54% | Maintains | 4 months ago |
Ekso Bionics Holdings IncEKSO | 15 | Buy | $60.00 | +1,400.00% | Maintains | 4 months ago |
Innate Pharma SaIPHA | 15 | Buy | $11.00 | +429.87% | Reiterates | 5 months ago |
Mindwalk Holdings CorpHYFT | 11 | Buy | $5.00 | +184.09% | Reiterates | 5 months ago |
Evaxion AEVAX | 12 | Buy | $14.00 | +379.45% | Reiterates | 5 months ago |
Spectral Ai IncMDAI | 4 | Buy | $3.50 | +75.88% | Reiterates | 5 months ago |
Edap Tms SaEDAP | 12 | Buy | $19.00 | +688.38% | Reiterates | 6 months ago |
Absci CorpABSI | 14 | Buy | $7.00 | +167.18% | Reiterates | 6 months ago |
In8bio IncINAB | 15 | Buy | $180.00 | +8,900.00% | Maintains | 6 months ago |
Electrocore IncECOR | 13 | Buy | $25.00 | +417.60% | Reiterates | 6 months ago |
Lifeward LtdLFWD | 16 | Buy | $13.00 | +2,213.17% | Reiterates | 6 months ago |
Iteos Therapeutics IncITOS | 11 | Buy | $46.00 | +353.20% | Reiterates | 6 months ago |
Janux Therapeutics IncJANX | 12 | Buy | $70.00 | +197.11% | Reiterates | 6 months ago |
Vericel CorpVCEL | 15 | Buy | $60.00 | +90.96% | Reiterates | 7 months ago |
Bicycle Therapeutics PLCBCYC | 16 | Buy | $33.00 | +381.05% | Reiterates | 7 months ago |
Leap Therapeutics IncLPTX | 13 | Buy | $5.50 | +1,679.94% | Reiterates | 8 months ago |
Quantum Si IncQSI | 6 | Buy | $5.50 | +336.51% | Reiterates | 8 months ago |
Affimed NvAFMDQ | 12 | Buy | $10.00 | +5,424.86% | Reiterates | 9 months ago |
Intensity Therapeutics IncINTS | 2 | Buy | $5.00 | +2,018.64% | Reiterates | 10 months ago |
Cyclo Therapeutics IncCYTH | 4 | Hold | $0.95 | N/A | Downgrades | a year ago |
Predictive Oncology IncPOAI | 1 | Buy | $3.00 | N/A | Initiates Coverage On | a year ago |
Asensus Surgical IncASXC | 11 | Hold | $0.35 | N/A | Reiterates | a year ago |
Mimedx Group IncMDXG | 8 | Buy | $11.00 | N/A | Reiterates | a year ago |
Calcimedica IncCALC | 1 | Buy | $20.00 | N/A | Reiterates | a year ago |
Avinger IncAVGR | 5 | Buy | $5.00 | N/A | Reiterates | a year ago |
Harpoon Therapeutics IncHARP | 8 | Hold | $23.00 | N/A | Downgrades | 2 years ago |
Solid Biosciences IncSLDB | 1 | Buy | $9.00 | N/A | Initiates Coverage On | 2 years ago |
Immunogen IncIMGN | 10 | Hold | $31.26 | N/A | Downgrades | 2 years ago |
Medicenna Therapeutics CorpMDNAF | 9 | Buy | $2.50 | N/A | Reiterates | 2 years ago |
Surface Oncology IncSURF | 6 | Hold | $5.00 | N/A | Downgrades | 2 years ago |
Alaunos Therapeutics IncTCRT | 3 | Buy | $225.00 | N/A | Upgrades | 2 years ago |
Surgalign Holdings IncSRGAQ | 3 | Buy | $3.50 | N/A | Reiterates | 2 years ago |
Codexis IncCDXS | 9 | Buy | $9.00 | N/A | Maintains | 3 years ago |
Lava Therapeutics NvLVTX | 1 | Buy | $9.00 | N/A | Reiterates | 3 years ago |
Celularity IncCELU | 2 | Buy | $25.00 | N/A | Maintains | 3 years ago |
Poseida Therapeutics IncPSTX | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Adagene IncADAG | 1 | Buy | $5.00 | N/A | Initiates Coverage On | 3 years ago |
Oncorus IncONCR | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cellectar Biosciences IncCLRB | 1 | Buy | $120.00 | N/A | Maintains | 3 years ago |
Aveo Pharmaceuticals IncAVEO | 4 | Hold | $15.00 | N/A | Downgrades | 3 years ago |
Calithera Biosciences IncCALA | 2 | Buy | $8.00 | N/A | Upgrades | 3 years ago |
Cervomed IncCRVO | 3 | Buy | $9.50 | N/A | Upgrades | 3 years ago |
Bioatla IncBCAB | 2 | Buy | $20.00 | N/A | Maintains | 3 years ago |
Jounce Therapeutics IncJNCE | 1 | Buy | $11.00 | N/A | Maintains | 3 years ago |
Notable Labs LtdNTBLQ | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Pulse Biosciences IncPLSE | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Hookipa Pharma IncHOOK | 5 | Buy | $80.00 | N/A | Maintains | 4 years ago |
Trillium Therapeutics IncTRIL | 3 | Hold | $18.50 | N/A | Downgrades | 4 years ago |
Carisma Therapeutics IncCARM | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Corvus Pharmaceuticals IncCRVS | 3 | Buy | $6.00 | N/A | Maintains | 4 years ago |
Kindred Biosciences IncKIN | 3 | Hold | $9.25 | N/A | Downgrades | 4 years ago |
Perspective Therapeutics IncCATX | 2 | Buy | $2.10 | N/A | Maintains | 5 years ago |
Inmune Bio IncINMB | 2 | Buy | $20.00 | N/A | Maintains | 5 years ago |
Intelgenx Technologies CorpIGXT | 1 | Buy | $0.50 | N/A | Reiterates | 5 years ago |
Casi Pharmaceuticals IncCASI | 1 | Buy | $35.00 | N/A | Maintains | 5 years ago |
Verastem IncVSTM | 1 | Buy | $33.00 | N/A | Maintains | 6 years ago |
Alphatec Holdings IncATEC | 2 | Buy | $9.50 | N/A | Reiterates | 6 years ago |
Redhill Biopharma LtdRDHL | 1 | Buy | $14,000.00 | N/A | Reiterates | 6 years ago |
Forty Seven IncFTSV | 1 | Hold | $95.50 | N/A | Downgrades | 6 years ago |
Correvio Pharma CorpCORV | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Ayala Pharmaceuticals IncADXS | 2 | Buy | $7,200.00 | N/A | Maintains | 8 years ago |
Aratana Therapeutics IncPETX | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 8 years ago |
Aceragen IncACGN | 1 | Buy | $4.00 | N/A | Initiates Coverage On | 8 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Buy | $14.00 | N/A | Assumes | 8 years ago |
Seaspine Holdings CorpSPNE | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.